Abacus dx offers laboratories the best equilibrium for HbA1c measurement between accuracy, robustness and throughput.
Diabetes is a major healthcare issue across ANZ affecting over 1.7 million Australians and over 200,000 New Zealanders.
Savyon Diagnostics is offering novel ELISA test for Haptoglobin (Hp) type determination in diabetic patients, which is directly associated with the risk of developing cardiovascular complication.
Sebia is pleased to release the new edition HbA1c Meta-Analysis.
Theradiag IMMUNO-TROL Quality Controls are unassayed non-kit controls. This means that the controls do not have values or reference ranges assigned by the manufacturer.